Insulet Corporation - Common Stock (NQ:PODD)

Topics Earnings

Insulet Announces Changes to Board of Directors with Retirements and New Appointments

January 18, 2024

Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

January 11, 2024

Exploring growth characteristics of INSULET CORP (NASDAQ:PODD).

INSULET CORP (NASDAQ:PODD) is a candidate for growth investors. Here's why. ↗

January 10, 2024

Via Chartmill

Expert Ratings For Insulet ↗

December 21, 2023

Via Benzinga

Should you consider NASDAQ:PODD for growth investing? ↗

December 19, 2023

Exploring growth characteristics of INSULET CORP (NASDAQ:PODD).

Via Chartmill

What 8 Analyst Ratings Have To Say About Insulet ↗

December 04, 2023

Via Benzinga

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

MoneyLion Inc. is a data-driven, digital financial platform. Insulet Corporation is a leading developer, manufacturer, and marketer of the Omnipod Insulin Management System.

Topics ETFs

Top Stock Picks For Week Of December 25, 2023 ↗

December 27, 2023

Via Talk Markets

Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday ↗

December 21, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Should you consider NASDAQ:PODD for growth investing? ↗

November 28, 2023

Why INSULET CORP (NASDAQ:PODD) qualifies as a high growth stock.

Via Chartmill

Insulet to Present at Upcoming Investor Conferences

November 28, 2023

INSULET CORP (NASDAQ:PODD) may be suited for growth investing, we'll explore why in this article.

Why the growth investor may take a look at NASDAQ:PODD. ↗

November 07, 2023

Via Chartmill

Expert Ratings for Insulet ↗

October 16, 2023

Via Benzinga

Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029

November 17, 2023

EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END

Via FinancialNewsMedia

10 Health Care Stocks Whale Activity In Today's Session ↗

November 15, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 10, 2023

Via Benzinga

Why Shares of Insulet Dropped This Week ↗

October 12, 2023

Positive news regarding diabetes therapy Ozempic worried investors.

Via The Motley Fool

Wall Street sees these 2023 losers as 2024 opportunities

November 09, 2023

Analysts are pointing at undervalued, oversold companies like these three S&P 500 laggards as potential investment opportunities heading into 2024.

The technology sector has done well during the recent stock market rally as seen in indices such as Nasdaq 100 and S&P 500.

Topics Stocks

What Stocks Drove The Recent Record Rally? A Breakdown You Can't Miss ↗

November 07, 2023

Via Benzinga

Topics Stocks

Large cap earnings trade ideas for risk-seeking investors

November 07, 2023

Positive earnings surprises (and the magnitude of surprises) are above historical norms as of late - and these three stocks could keep the party going.

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

Topics Economy

Barron's Weekend Stock Picks: Chevron, Apple, Disney And Insulet's Stock Increase ↗

November 04, 2023

Via Benzinga

Insulet Surges After Eye-Popping Earnings Growth Wallops Expectations ↗

November 03, 2023

Insulet makes an insulin pump called Omnipod. U.S. sales are on the rise.

Via Investor's Business Daily

Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday ↗

November 03, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Omnipod Insulin Pump Working Well For Insulet, Lifts Annual Forecast ↗

November 03, 2023

Insulet Corporation (NASDAQ: PODD) reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the

Via Benzinga

Insulet Reports Third Quarter 2023 Revenue Increase of 27% Year-Over-Year (25% Constant Currency1)

November 02, 2023

Insulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout November

November 01, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Via Investor's Business Daily

Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone

October 23, 2023